A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh for a fraction of the American price, may give some families around the world an unlikely lifeline.
Review shows majority of procedures offered alongside standard IVF not backed by reliable evidence Most IVF “add-on” treatments sold to people hoping to boost their chances of having children are not backed by reliable evidence, fail to boost fertility and may be a complete waste of money, the largest study of its kind has concluded.There…
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
More U.S. scientists are heading abroad. Three researchers explain why they decided to shift their research to universities in the U.K.